Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

Introducing the M@P nanoplatform: a novel approach to cancer therapy that triggers pyroptosis and ferroptosis, boosting ...

January 13, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that the now complete findings from our previously announced pre-clinical breast cancer ...

Recent advances in pancreatic cancer detection are offering hope, with new techniques and technologies aiming to identify the ...

Atara Biotherapeutics ATRA is a nimble allogeneic T cell immunotherapy company with several near-term catalysts. This Zacks Rank #2 (Buy) company boasts a pipeline of differentiated therapies across a ...

Building on decades of the Company's Alzheimer's research, two differentiated investigational therapies aim to slow ...

Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a ...

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who ...

Rosa underwent four cycles of treatment as an inpatient, each involving eight days of chemotherapy, immunotherapy, steroids ...

That small trial and its remarkable results epitomize the ideal of modern cancer research: patients were enrolled based on a ...

Healthcare stocks, especially biopharmaceuticals, are forecasted to outperform the market due to four key investment themes.